Additional file 2 of Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

Authors :: Bliss, Judith M.
Tovey, Holly
Evans, Abigail
Holcombe, Chris
Horgan, Kieran
Mallon, Elizabeth
Vidya, Raghavan
Skene, Anthony
Dodson, Andrew
Hills, Margaret
Detre, Simone
Zabaglo, Lila
Banerji, Jane
Kilburn, Lucy
Morden, James P.
Robertson, John F. R.
Smith, Ian
Dowsett, Mitch
Publication Year :: 2023
Publisher :: figshare, 2023.
Abstract: Additional file 2: Fig. S2. Distribution of A. log(Ki67Baseline +0.1) for all patients, B. log(Ki672week +0.1) in patients allocated control, C. log fold. change Ki67 in patients allocated control, D. log(Ki672week +0.1) in patients allocated AI and E. log fold change Ki67 in patients allocated AI. Presented separately for HER2- and HER2+ patients.

Full Text Access

Tools